Metabolite of cancer medication shows promise for Parkinson’s
A metabolite called M324 of the cancer medicine rucaparib is able to reduce the abnormal accumulation of alpha-synuclein protein in…
Articles by Andrea Lobo
Grant will advance VNA-318 for Parkinson’s, age-related diseases
The Swiss company Vandria has been awarded a multimillion-dollar research grant to help advance the development of VNA-318, its…
Long-term tai chi for Parkinson’s patients may improve cognition
Long-term practice of the Chinese martial art tai chi for Parkinson’s disease was shown to ease nonmotor symptoms among patients…
Parkinson’s clinical trial of iRegene’s NouvNeu001 doses 1st patient
The first patient has been dosed, and the observation period completed, in a clinical trial in China that’s testing iRegene…
Vaxxinity, University of Florida join for work on Parkinson’s vaccine
Vaxxinity has entered into a research collaboration with the University of Florida to advance the development of vaccines…
Knight gains rights to IPX203, for off times, in Canada and Latin America
Knight Therapeutics has entered into an exclusive license agreement with Amneal Pharmaceuticals giving it rights to apply…
MJFF grant supports work into oral therapy to protect nerve cells
The Michael J. Fox Foundation for Parkinson’s Research (MJFF) has awarded an $873,000 grant to Vesper Bio…
Centogene, MJFF partner to study GBA gene in Parkinson’s patients
Centogene and The Michael J. Fox Foundation (MJFF) are teaming up on a research project to investigate genetic risk…
Brain imaging method may aid mild traumatic brain injury diagnosis
A new brain imaging method may help diagnose mild traumatic brain injury (mTBI), which according to some studies can be…
Home-based digital monitoring discerns motor fluctuation profiles
Monitoring symptoms at home using smartwatch-smartphone technology collected individual profiles of tremor and activity fluctuations among people with advanced…